Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified
Conditions
Interventions
Intervention1: hydrocortisone gel phonophoresis: The transducer head of therapeutic ultrasound, will be placed over the trigger points in a
circular motion with the help of ultrasound jelly and 5g 1%
Sponsors
Fathimathu Thasneem A K
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Temporomandibular myofascial pain syndrome as diagnosed with myofascial pain DC/TMD diagnostic criteria and not responding to one-month routine medical management. Patients between 20 to 50 years of age, unilateral pain, pain on palpation of muscles of mastication, joint sound (clicking), restricted mouth opening, no joint tenderness palpating through external auditory meatus, and no clinical, radiographic, or biochemical evidence of organic joint disease (Laskin’s criteria) were included
Exclusion criteria
Exclusion criteria: 1.Traumatic conditions, ankylosis, neoplastic changes, developmental defects, degenerative joint diseases affecting the TMJ. 2.Patients with clicking of TMJ, but without pain or restricted mandibular movements 3. Patients with undiagnosed dental pain or who have skin lesions or facial abrasion at the site of acoustic gel placement. 4. Patients with cardiac pacemakers and cardiac arrhythmias and other uncontrolled systemic diseases. 5. Vascular disorders and neurological pain 6. Patients with any history of seizures 7. Pregnant and lactating mothers 8. Mentally disabled patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effectiveness of hydrocortisone phonophoresis and therapeutic ultrasound in reducing pain intensity in patients with temporomandibular myofascial pain syndrome as measured by reduction in intensity of pain (VAS score) and masticatory muscle tenderness (grading for muscle tenderness) and subsequent improvement in mouth opening. Mouth opening will be assessed as pain-free maximum mouth opening (MMO) in mm from baseline to last follow up treatment visit.Timepoint: The outcome will be assessed at baseline, first week, first month, second month and third month following treatment phase | — |
Secondary
| Measure | Time frame |
|---|---|
| To describe the adverse effects of therapeutic US & phonophoresis, if any during treatment and follow- up period. To report patterns of symptom-free interval & recurrence during post treatment follow- up period of 3 months.Timepoint: The outcome will be assessed at baseline, first week, first month, second month & third month following treatment phase | — |
Countries
India
Contacts
Public ContactDr Nileena R Kumar
Government Dental College Kozhikode
Outcome results
None listed